A surge in coronavirus cases in Europe means that talk of a swift recovery is now a “summer memory”, says Peter Goodman in The New York Times. French prime minister Jean Castex this week acknowledged that “the second wave is here”, as governments across the continent tightened restrictions. Spain has declared a state of emergency in Madrid and instituted a partial lockdown there.
Economic gloom is spreading. France now expects activity to remain stuck at 95% of pre-pandemic levels for the rest of the year. Spanish business sentiment hit a four-month low last month. The pan-European Europe Stoxx 600 index is down 11% so far this year.
The changing of the guard
The common investment “trope” is that Europe is full of “old economy” firms while the US races ahead with technology, says Graham Secker in the Financial Times. Yet that idea is “outdated”. Banks and energy no longer dominate the MSCI Europe index. Indeed, the weighting of banks on European indices is now the same as the global average. The areas where European markets are “overweight” the global average today – healthcare, consumer staples and industrials – offer a “healthy mix of good, quality growth”. The European “leopard is indeed changing its spots”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
If the US market is increasingly a wager on tech, then Europe is “a bet on drugs”, says Stephen Wilmot in The Wall Street Journal. Five of its ten biggest firms are now drugs firms. Back in 2004 the top three Stoxx Europe 50 firms were all British: BP, HSBC and Vodafone. Today’s leading trio are Swiss: two pharmaceutical giants (Roche and Novartis) and Nestlé. Europe offers other “growth niches” as well, from French luxury goods to Danish cleantech (energy efficiency), says Reshma Kapadia in Barron’s. America’s S&P 500 has “eviscerated” other markets over the past decade, “returning 13.9% a year, on average” against 5.5% for the World ex-US.
Yet stretched valuations are giving Americans the “urge to do some portfolio globe-trotting”. If we strip out expectations about growth and just look at current valuations, then US equities are “priced to deliver” just 0.5% in annual real returns over the next decade, says Robert Arnott, the founder of Research Affiliates. Europe and Japan are offering real returns of “about 5%”.
A German anchor
Germany’s Dax has outperformed other European markets this year, falling by just 2.2%, thanks to the country’s export-led exposure to the strong Chinese recovery, says Anna Isaac in The Wall Street Journal. Analysts think German carmakers will also get a boost as the pandemic makes more people avoid public transport. In 2018 the debt of German non-financial companies was about 58% of GDP, compared with 84% in the UK and 141% in France. As Christoph Ohme of DWS Group puts it, strong public and corporate finances make Germany resilient in a crisis. It is a “stable anchor” for the world economy.
Stocks and shares ISAs beat cash ISAs despite rising interest rates
Exclusive analysis for MoneyWeek shows that the stock market beat cash ISAs last year - and when inflation is factored in, cash savers actually made a loss. We run through the figures.
By Ruth Emery Published
Waspi women: could they get £10,000 compensation under new bill?
Many women born in the 1950s got a raw deal due to the rising state pension age. The “Waspi” campaign group has been lobbying for compensation for years - we outline the journey so far, and whether they might finally receive some money.
By Ruth Emery Published
Three high-quality global companies for growth
James Harries, a senior fund manager at STS Global Income & Growth Trust highlights three favourites.
By James Harries Published
Four high-quality stocks set for decades of dividend and earnings growth
Charles Luke, an investment manager for Murray Income Trust, highlights four favourite high-quality stocks.
By Charles Luke Published
Humana sees healthy growth in US healthcare
Humana is a major player in the American market and the stock’s valuation looks reasonable.
By Stephen Connolly Published
The nobbling of Britain’s nuclear energy sector
The UK once led the world in atomic power, but now it’s a has-been. The malaise is due to the left’s opposition to the sector and decisions taken by the Blair government.
By Max King Published
Five fantasy deals to hope for this year
From Amazon buying John Lewis to Warren Buffet taking on Unilever, these fantasy deals, mergers and acquisitions would improve the companies involved.
By Matthew Lynn Published
Stay safe: A financial crisis could still be around the corner
Investors were cheered by rate cuts, but Bill Bonner says don't get too excited…
By Bill Bonner Published
Why Laurent-Perrier could be a good buy
The market is overlooking Laurent-Perrier’s status as a top Champagne producer.
By Rupert Hargreaves Published
How fintech has gone mainstream
Once a niche sector, fintech went mainstream in 2023.
By David C. Stevenson Published